Head-to-head review
Found vs Noom Med
Found and Noom Med both compete for patients searching for a GLP-1 weight-loss program. This head-to-head compares pricing, medications, insurance handling, and clinician quality so you can pick the right fit.
Editorial verdict
Found wins on starting price at $99/mo. Pick the program whose medications and care model best match your treatment plan.
Side-by-side comparison
Every attribute scored head-to-head. The highlighted cell is our pick for that row.
Found
4.2 / 5Noom Med
4.1 / 5Found
$99/moNoom Med
$149/moFound
Prescription ProgramNoom Med
Prescription ProgramFound
- Wegovy
- Zepbound
- Compounded Semaglutide
- Contrave
- Metformin
Noom Med
- Wegovy
- Zepbound
- Saxenda
- Contrave
- Metformin
- Compounded Semaglutide
Found
All 50 statesNoom Med
All 50 statesFound
YesNoom Med
YesFound
NoNoom Med
NoFound
YesNoom Med
YesFound
4.2Behavior-change first, medication when appropriate
Found takes a more holistic approach, treating GLP-1s as one tool among many. Best suited to patients who value coaching and behavior change alongside their prescription.
Pros
- Strong coaching curriculum
- Personalized medication selection
- Transparent about non-medication paths
Cons
- Less GLP-1-centric than competitors
- App-only support model
Noom Med
4.1Behavioral psychology + GLP-1 prescribing
Noom Med extends Noom's psychology-first weight-loss app into a clinical service, layering GLP-1 prescribing on top of one of the most established behavior-change platforms in the category.
Pros
- Industry-leading behavior-change curriculum
- Clinician oversight from obesity medicine specialists
- Insurance pathway available for brand-name GLP-1s
Cons
- Medication costs are separate
- App-first model has limited live human support
Other head-to-head reviews
Cost, coverage & condition context
Use these resources to pressure-test which program fits your budget, insurance, and clinical situation.
Cost
GLP-1 pricing breakdown
Real monthly cost in every common scenario.
Open
Insurance
Coverage by insurer
BCBS, UHC, Aetna, Cigna, Kaiser & Medicare matrix.
Open
Condition
GLP-1 for diabetes
When insurers cover Ozempic and Mounjaro.
Open
Condition
GLP-1 for sleep apnea
Zepbound's OSA indication can unlock denials.
Open
By state
GLP-1 in California
Local prescribing rules and licensed programs.
Open
By state
GLP-1 in Texas
Texas insurance landscape and top brands.
Open